Performance of the HEMORR 2 HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in nonwarfarin anticoagulated atrial fibrillation patients

J Am Coll Cardiol. 2013 Jan 22;61(3):386-7. doi: 10.1016/j.jacc.2012.10.010. Epub 2012 Dec 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anticoagulants / adverse effects*
  • Atrial Fibrillation / drug therapy*
  • Female
  • Hemorrhage / chemically induced*
  • Humans
  • Male
  • Middle Aged
  • Oligosaccharides / therapeutic use
  • Outcome Assessment, Health Care*
  • Predictive Value of Tests
  • Proportional Hazards Models
  • Risk Assessment

Substances

  • Anticoagulants
  • Oligosaccharides
  • idraparinux